Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies

[1]  G. Jaffe,et al.  Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results. , 2020, Ophthalmology.

[2]  S. Narang,et al.  Retinal imaging in incontinentia pigmenti , 2019, Indian journal of ophthalmology.

[3]  G. Jaffe,et al.  Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results. , 2019, Ophthalmology.

[4]  C. Mayer,et al.  Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema , 2019, Journal of Ophthalmic Inflammation and Infection.

[5]  Vishali Gupta,et al.  Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis , 2019, Indian journal of ophthalmology.

[6]  I. Immonen,et al.  Fluocinolone acetonide intravitreal implant (Retisert®) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis‐related uveitis , 2018, Acta ophthalmologica.

[7]  A. Dick,et al.  Managing juvenile idiopathic arthritis-associated uveitis. , 2016, Survey of ophthalmology.

[8]  A. Adán,et al.  Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus , 2015, Rheumatology International.

[9]  M. Mikhail,et al.  Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye , 2013, Medical hypothesis, discovery & innovation ophthalmology journal.

[10]  J. Vander.  Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis , 2012 .

[11]  C. Lowder,et al.  Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. , 2011, Archives of ophthalmology.

[12]  P. McCluskey,et al.  Outcome of intravitreal triamcinolone in uveitis. , 2005, Ophthalmology.